Related Experiment Video
Updated: Mar 12, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Sinonasal methicillin-resistant Staphylococcus aureus: updates on treatment
Fahad Al-Asousi1, Anali Dadgostar, Amin Javer
1St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, Canada.
Managing methicillin-resistant Staphylococcus aureus (MRSA) in chronic rhinosinusitis is challenging. Promising new treatments include topical antibiotics and nonantibiotic therapies like photodynamic therapy and colloidal silver.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Microbiology
Background:
- Chronic rhinosinusitis (CRS) management is complicated by methicillin-resistant Staphylococcus aureus (MRSA).
- Sinonasal MRSA infections are associated with recalcitrant disease, posing significant clinical challenges.
- Traditional antibiotic approaches have yielded unsatisfactory outcomes for MRSA CRS.
Purpose of the Study:
- To review current management strategies for sinonasal MRSA infections.
- To explore novel treatment modalities for MRSA-related chronic rhinosinusitis.
- To highlight the importance of understanding emerging nonantibiotic treatments.
Main Methods:
- Literature review of current and emerging treatments for sinonasal MRSA.
- Analysis of topical antibiotic therapies (ofloxacin, mupirocin).
- Evaluation of nonantibiotic modalities (antimicrobial photodynamic therapy, colloidal silver).
Main Results:
- Topical ofloxacin drops and mupirocin ointments show beneficial results for MRSA chronic sinusitis (off-label use).
- Emerging nonantibiotic options, including antimicrobial photodynamic therapy and colloidal silver irrigation, demonstrate promising outcomes.
- Systemic and local antibiotic advancements have been slow and insufficient.
Conclusions:
- MRSA is a significant factor in difficult-to-treat chronic rhinosinusitis.
- The shift towards nonantibiotic antibacterial treatments is critical for improving patient outcomes.
- Clinicians must be aware of novel therapeutic options for effective MRSA sinonasal infection management.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mitral Stenosis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Suctioning the Nasopharyngeal Airway
Equipment Required

